A Pilot Study of Bendamustine and Rituximab Alternating With Cytarabine and Rituximab for Untreated Mantle Cell Lymphoma
Phase of Trial: Phase I
Latest Information Update: 08 Feb 2018
At a glance
- Drugs Bendamustine (Primary) ; Cytarabine (Primary) ; Pegfilgrastim; Rituximab
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- 18 Apr 2016 Planned End Date changed from 1 May 2023 to 1 Apr 2023.
- 18 Apr 2016 Planned primary completion date changed from 1 Oct 2018 to 1 Sep 2018.
- 18 Apr 2016 Status changed from not yet recruiting to recruiting.